Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.